Is CASI Pharmaceuticals Inc (CASI) Stock at the Top of the Biotechnology Industry?

CASI Pharmaceuticals Inc (CASI) is around the top of the Biotechnology industry according to InvestorsObserver. CASI received an overall rating of 90, which means that it scores higher than 90 percent of all stocks. CASI Pharmaceuticals Inc also achieved a score of 99 in the Biotechnology industry, putting it above 99 percent of Biotechnology stocks. Biotechnology is ranked 43 out of the 148 industries.

CASI has an Overall Score of 90. Find out what this means to you and get the rest of the rankings on CASI!

See Full CASI Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 90 would rank higher than 90 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With CASI Pharmaceuticals Inc Stock Today?

CASI Pharmaceuticals Inc (CASI) stock has gained 0.27% while the S&P 500 is lower by -0.2% as of 9:48 AM on Thursday, Nov 16. CASI is higher by $0.01 from the previous closing price of $4.35 on volume of 8,638 shares. Over the past year the S&P 500 is higher by 13.52% while CASI is higher by 130.69%. CASI lost -$3.04 per share the over the last 12 months. Click Here to get the full Stock Report for CASI Pharmaceuticals Inc stock.